Private Placement

Amid a volatile market, Ligand presents its sustainable growth blueprint, powered by royalties and partnerships, to top investors this March.

The Good Game app launches in Kansas, promising to unite the fragmented youth sports market with a single platform for booking, safety, and gig work.

With a new C-suite hire, Utah's Silicon Ridge project is poised to become a cornerstone of America's strategic mineral independence from a single deposit.

A major investment from All Seas Capital will fuel Sereni's rapid consolidation of Europe's fragmented funeral industry, signaling a new era of modernization.

The WPIC forecasts another major platinum deficit for 2026, signaling continued market tightness, price support, and a complex global supply struggle.

A 10-year, $25M program created 108 palliative care leaders. A new report reveals its impact on a field facing a critical workforce and access crisis.

A new partnership between investor NightDragon and nonprofit SVDG aims to fast-track cyber, AI, and dual-use tech for national security.

A new MMA league is letting fans and fighters buy in. With veteran leaders and a $5M equity raise, can the Global Fight League disrupt the octagon?

Once a failing firm, Aurelion Inc. bet its future on tokenized gold. The gamble paid off with a profitable quarter, but regulatory risks loom large.

Despite massive AI spending, a new report shows only a third of projects are profitable, pointing to hidden costs in data storage and cloud security.

Phoenix innovator GACW proves its steel Air Suspension Wheel in brutal -40°F mining tests, paving the way for a safer, non-pneumatic 2026 commercial release.

As co-founder Matthew Bush takes the helm, Hirebotics doubles down on its mission to empower fabricators with user-friendly robots amid a historic labor crisis.

A new partnership gives thousands of young athletes in Las Vegas free recovery tech while a unique manufacturing model boosts the local economy.

With $65M in new funding and a new CEO, Duos is betting big on a $200M NVIDIA GPU deal to become a key player in the booming Edge AI infrastructure market.

A novel sputum test could end the trial-and-error approach for millions with chronic respiratory disease, promising a new era of personalized medicine.

Daxor reports a transformative year with 45% revenue growth, a new FDA-cleared portable analyzer, and a full pivot to a high-growth medtech company.

Axxess's upcoming conference tackles AI's role in home health, unveils a new leadership certification, and honors an industry titan. Here's what it means.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

Greenwich LifeSciences' Phase III trial for its GLSI-100 immunotherapy is enrolling patients faster than ever, with early data echoing past success.

A massive US$175M investment in EverWind is set to transform Nova Scotia into a clean energy powerhouse, with a groundbreaking Indigenous partnership at its core.